{
    "id": "1181",
    "question": "A 21-year-old woman comes to the physician for evaluation of excess hair growth on her face. Menses occur irregularly at 45 to 65-day intervals. She is 159 cm (5 ft 3 in) tall and weighs 59 kg (130 lb); BMI is 23 kg/m2. Physical examination shows facial acne and growth of coarse dark hair on the face, chest, and lower back. Pelvic examination shows no abnormalities. Serum studies show:\nSodium 141 mEq/L\nPotassium 4.2 mEq/L\nGlucose 109 mg/dL\nCortisol (1600 h) 4 \u03bcg/dL\nProlactin 14 ng/mL\n17-hydroxyprogesterone 390 ng/dL (N=20\u2013300 ng/dL)\nTestosterone 91 ng/dL (N=8\u201360 ng/dL)\nA urine pregnancy test is negative. This patient's condition is most likely associated with which of the following?\"",
    "options": {
        "A": "Hyperproliferation of theca interna cells",
        "B": "Exogenous anabolic steroid use",
        "C": "Ovarian fibrosis and multiple cystic follicles",
        "D": "Hyperplasia of the adrenal cortex"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To solve this question, we need to analyze the patient's symptoms and laboratory results. The patient presents with excess hair growth on her face, chest, and lower back, irregular menses, and elevated 17-hydroxyprogesterone and testosterone levels. These symptoms and laboratory results are suggestive of hyperandrogenism, which can be caused by various conditions, including ovarian and adrenal causes. The elevated 17-hydroxyprogesterone level is particularly notable, as it is often associated with congenital adrenal hyperplasia (CAH) or other adrenal disorders. The patient's age and presentation also make PCOS less likely, as PCOS typically presents with elevated androgen levels, but not typically with such a high 17-hydroxyprogesterone level. Therefore, the most likely cause of this patient's condition is an adrenal disorder, specifically hyperplasia of the adrenal cortex. The elevated cortisol level is also consistent with this diagnosis. Options A, B, and C are less likely, as they do not explain the elevated 17-hydroxyprogesterone level or the patient's symptoms. Therefore, the correct answer is D. Hyperplasia of the adrenal cortex is the most likely cause of this patient's condition.\", \"answer_choice\": \"D\"}",
    "snippets": [
        {
            "id": "Gynecology_Novak_5463",
            "title": "Gynecology_Novak",
            "content": "In the past, testing for androgen conjugates (e.g., 3\u03b1-androstenediol G [3\u03b1-diol G] and androsterone G [AOG] as markers for 5\u03b1-reductase activity in the skin) was advocated. Routine \u22659 Adult onset adrenal hyperplasia >1000 <10,000 ng/dL Hirsutism Ferriman \u2013 Gallwey score \u22648 24-hour urinary cortisol Trial of OCPs, cosmetic, and dermatologic treatments >45 g/day ACTH stimulation test >300 ng/dL Cushing evaluation Plus: Moon facies, plethora, striae, dorsoclavicular or supraclavicular fat pads, proximal muscular weakness Assess for PCOS, AOAH, HAIR-AN, ovarian or adrenocortical tumor or other* 17-OH progesterone bioavailable testosterone (total and free included) No response 48-hour low-dose dexamethasone suppression: 40% suppression of T \u0081 11-desoxycortisol >7 ng/mL, \u0081 24-hour urinary cortisol >45 g/day, \u0081 DHEAS >360 g/dL Total T >200 ng/dL Elevated values consistent with Ovarian Tumor or Adrenocortical Tumor Total T >80 <150 ng/dL, bioavailable or free T mildly elevated, endocrine"
        },
        {
            "id": "Gynecology_Novak_5499",
            "title": "Gynecology_Novak",
            "content": "4. Oophorectomy in patients with hyperthecosis accompanied by hyperinsulinemia and hyperandrogenemia does not change insulin resistance, despite a decrease in androgen levels (70,71). Acanthosis nigricans is a reliable marker of insulin resistance in hirsute women. This thickened, pigmented, velvety skin lesion is most often found in the vulva and may be present on the axilla, over the nape of the neck, below the breast, and on the inner thigh (72). The HAIR-AN syndrome consists of hyperandrogenism (HA), insulin resistance (IR), and acanthosis nigricans (AN) (68,73). These patients often have high testosterone levels (>150 ng/dL), fasting insulin levels of greater than 25 \u03bcIU/mL (normal <20 to 24 \u03bcIU/mL), and maximal serum insulin responses to glucose load (75 gm) exceeding 300 \u03bcIU/mL (normal is <160 \u03bcIU/m: at 2 hours postglucose load)."
        },
        {
            "id": "First_Aid_Step2_825",
            "title": "First_Aid_Step2",
            "content": "PCOS Irregular menses, slow-onset hirsutism, obesity, infertility, hypertension, a family history of PCOS or DM. Fasting glucose, insulin/lipid prof le, BP, ultrasound for ovarian cysts. 21-hydroxylase def ciency\u2014nonclassic (late-onset) CAH Severe hirsutism or virilization, a strong family history of CAH, short stature, signs of defeminization. More common among Ashkenazi Jews. 17-hydroxyprogesterone (17-HP) levels before and after ACTH stimulation test > 10 ng/dL; CYP21 genotype. 21-hydroxylase def ciency\u2014classic (congenital) CAH Same as above but with congenital virilization. 17-HP levels > 30 ng/dL. Hypothyroidism Fatigue, weight gain, amenorrhea. TSH. Hyperprolactinemia Amenorrhea, galactorrhea, infertility. Prolactin. Androgen-secreting neoplasm Pelvic mass, rapid-onset hirsutism or virilization, > 30 with onset of symptoms. Pelvic ultrasound or abdominal/pelvic CT. Cushing\u2019s syndrome Hypertension, buffalo hump, purple striae, truncal obesity. Elevated BP plus dexamethasone"
        },
        {
            "id": "Gynecology_Novak_5466",
            "title": "Gynecology_Novak",
            "content": "17-hydroxypregnenolone/17-hydroxyprogesterone ratio of 11 compared to 3.4 in normals. 11\u03b2-hydroxylase deficiency presents with hypertension in the first years of life in two thirds of patients. The mild form presents with vitalization or precocious puberty without hypertension. Undiagnosed adults demonstrate hirsutism, acne, and amenorrhea. Diagnosis is confirmed with an 11-desoxycortisol level >25 ng/mL 60 minutes after ACTH(1-24) stimulation. ACTH, adrenocorticotropic hormone; AOAH, adult-onset adrenal hyperplasia; DHEAS, dehydroepiandrosterone sulfate; HAIR-AN, hyperandrogenemia, insulin resistance-acanthosis nigricans. (See references 2\u201311,15.)"
        },
        {
            "id": "Gynecology_Novak_5552",
            "title": "Gynecology_Novak",
            "content": "Although most patients with Cushing syndrome gain weight, some lose it. Obesity is typically central, with characteristic redistribution of fat over the clavicles around the neck and on the trunk, abdomen, and cheeks. Cortisol excess may lead to insomnia, mood disturbances, depression, and even overt psychosis. With overproduction of sex steroid precursors, women may exhibit hyperandrogenism (hirsutism, acne, oligomenorrhea or amenorrhea, thinning of scalp hair). Masculinization is rare, and its presence suggests an autonomous adrenal origin, most often an adrenal malignancy. With overproduction of mineralocorticoids, patients may manifest arterial hypertension and hypokalemic alkalosis. The associated \ufb02uid retention may cause pedal edema (Table 31.7) (154)."
        },
        {
            "id": "InternalMed_Harrison_26466",
            "title": "InternalMed_Harrison",
            "content": "FIGURE 403-1 Pituitary adenoma. Coronal T1-weighted postcontrast magnetic resonance image shows a homogeneously enhancing mass (arrowheads) in the sella turcica and suprasellar region compatible with a pituitary adenoma; the small arrows outline the carotid arteries. Acromegaly Serum IGF-I Interpret IGF-I relative to ageand sex-matched controls Oral glucose tolerance Normal subjects should test with GH obtained suppress growth hormone at 0, 30, and 60 min to <1 g/L MRI of the sella should be ordered if PRL is elevated Cushing\u2019s disease 24-h urinary free cortisol Ensure urine collection is total and accurate Dexamethasone (1 mg) Normal subjects suppress to at 11 P.M. and fasting <5 g/dL plasma cortisol measured at 8 A.M. Abbreviations: ACTH, adrenocorticotropin hormone; GH, growth hormone; IGF-I, insulin-like growth factor I; MRI, magnetic resonance imaging; PRL, prolactin."
        },
        {
            "id": "Gynecology_Novak_5583",
            "title": "Gynecology_Novak",
            "content": "Patients with severe hirsutism, virilization, or recent and rapidly progressing signs of androgen excess require careful investigation for the presence of an androgen-secreting neoplasm. The two most common sources of androgen-secreting tumors are the adrenal glands and the ovaries. To assess the symptoms, serum and urine tests for androgens and their metabolites should be obtained along with modern abdominal imaging techniques such as CT, MRI, and ultrasound scans (194). In prepubertal girls, virilizing tumors may cause signs of heterosexual precocious puberty in addition to hirsutism, acne, and virilization. In patients suspected of harboring an adrenal or ovarian tumor because of rapidly progressing or severe hyperandrogenism, the bioavailable testosterone level (free testosterone level above 6.85 pg/mL; 23.6 pmol/L), followed by an11-desoxycortisol (above 7 ng/mL; 20.2 nmol/L), DHEAS (>3.6 \u03bcg/mL) and a 24-hour urinary cortisol (>45 \u03bcg per day) are the most sensitive and specific"
        },
        {
            "id": "First_Aid_Step2_823",
            "title": "First_Aid_Step2",
            "content": "Hirsutism = male hair pattern. Virilization = frontal balding, muscularity, clitoromegaly, and deepening of the voice. Defeminization = \u2193 breast size; loss of feminine adipose tissue. The most severe form of PCOS is HAIR-AN syndrome: HyperAndrogenism, Insulin Resistance, and Acanthosis Nigricans. \u25a0\u2191 androgens (testosterone > 2 ng; DHEAS > 7 \u03bcg/mL): Rule out adrenal or ovarian neoplasm. \u25a0\u2191 serum testosterone: Suspect an ovarian tumor. \u25a0\u2191 DHEAS: Suspect an adrenal source (adrenal tumor, Cushing\u2019s syn drome, CAH). \u25a0\u2191 17-OH progesterone levels (either basally or in response to ACTH stimulation). \u25a0Table 2.12-5 outlines the differential diagnosis of hyperandrogenism. Glucocorticoids (e.g., prednisone). Medical therapy for adrenal and ovarian disorders prevents new terminal hair growth but does not resolve hirsutism. Laser ablation, electrolysis, or conventional hair removal techniques must be used to remove unwanted hair."
        },
        {
            "id": "Gynecology_Novak_5216",
            "title": "Gynecology_Novak",
            "content": "Figure 29.22 Left: A 19-year-old girl with secondary amenorrhea and severe acne and hirsutism beginning at the normal age of puberty. Stimulatory testing with corticotropin documented nonclassic 21-hydroxylase deficiency. Flattening of the breasts is apparent. She was shorter than her one sister and her mother."
        },
        {
            "id": "Biochemistry_Lippincott_1244",
            "title": "Biochemistry_Lippinco",
            "content": "Choose the ONE best answer. For Questions 26.1 and 26.2, use the following scenario. A 40-year-old woman, 5 ft, 1 in (155 cm) tall and weighing 188 lb (85.5 kg), seeks your advice on how to lose weight. Her waist measured 41 in and her hips 39 in. The remainder of the physical examination and the blood laboratory data were all within the normal range. Her only child (who is age 14 years), her sister, and both of her parents are overweight. The patient recalls being overweight throughout her childhood and adolescence. Over the past 15 years, she had been on seven different diets for periods of 2 weeks to 3 months, losing from 5 to 25 lb each time. On discontinuation of the diets, she regained weight, returning to 185\u2013190 lb. 6.1. Calculate and interpret the body mass index for the patient. Body mass index (BMI) = weight in kg/(height in m)2 = 85.5/1.552 = 35.6. Because her BMI is >30, the patient is classified as obese."
        },
        {
            "id": "Gynecology_Novak_5369",
            "title": "Gynecology_Novak",
            "content": "3. The patient\u2019s history of weight changes, exercise, eating habits, and body image is an important factor in determining whether anorexia nervosa, malnutrition, obesity, exercise, or stress may be responsible for amenorrhea. Patients with certain specific clinical findings should undergo screening for other hormonal alterations: 1. Androgen levels should be assessed in any hirsute patient to ensure that adrenal and ovarian tumors are not present and to aid in the diagnosis of PCOS. 2. Acromegaly is suggested by coarse facial features, large doughy hands, and hyperhidrosis and may be confirmed by measuring IGF-1 levels. 3. In patients with truncal obesity, hirsutism, hypertension, and erythematous striae, Cushing syndrome should be ruled out by assessing 24-hour urinary cortisol levels or performing a 1-mg overnight dexamethasone suppression test or late night salivary cortisol (126). It is important to confirm that the patient is not taking exogenous glucocorticoid."
        },
        {
            "id": "InternalMed_Harrison_3597",
            "title": "InternalMed_Harrison",
            "content": "Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples David B. Mount, Thomas D. DuBose, Jr. CASE 1 64e A 23-year-old woman was admitted with a 3-day history of fever, cough productive of blood-tinged sputum, confusion, and orthostasis. Past medical history included type 1 diabetes mellitus. A physical examination in the emergency department indicated postural hypo-tension, tachycardia, and Kussmaul respiration. The breath was noted to smell of \u201cacetone.\u201d Examination of the thorax suggested consolidation in the right lower lobe. Sodium 130 meq/L Potassium 5.0 meq/L Chloride 96 meq/L CO2 14 meq/L Blood urea nitrogen (BUN) 20 mg/dL Creatinine 1.3 mg/dL Glucose 450 mg/dL Pneumonic infiltrate, right lower lobe The diagnosis of the acid-base disorder should proceed in a stepwise fashion: 1. The normal anion gap (AG) is 8\u201310 meq/L, but in this case, the AG is elevated (20 meq/L). Therefore, the change in AG (\u0394AG) = ~10 meq/L. 2."
        },
        {
            "id": "Gynecology_Novak_5188",
            "title": "Gynecology_Novak",
            "content": "Figure 29.18 Left: A71/2-year-old girl with Tanner stage 4 pubertal development who began menstruating 1 month earlier. She was 57 inches tall (above the 95th percentile). Luteinizing hormone and follicle-stimulating hormone levels were consistent with her development. A large neoplasm that proved to be a hypothalamic hamartoma was present on computed tomography scan. Pubertal development began at about 5 years of age. Figure 29.19 Right: A: A101/2-year-old girl with 21-hydroxylase deficiency before treatment. 17-Ketosteroid (KS) excretion was 34 mg per day. B: The same patient after 9 months of therapy with cortisone (17-KS excretion: 4.6 mg per day). (From Wilkins L. The diagnosis and treatment of endocrine disorders in childhood and adolescence. 3rd ed. Springfield, IL: Charles C Thomas, 1965:439, with permission.)"
        },
        {
            "id": "Gynecology_Novak_5584",
            "title": "Gynecology_Novak",
            "content": "above 6.85 pg/mL; 23.6 pmol/L), followed by an11-desoxycortisol (above 7 ng/mL; 20.2 nmol/L), DHEAS (>3.6 \u03bcg/mL) and a 24-hour urinary cortisol (>45 \u03bcg per day) are the most sensitive and specific for the detection of an androgen-secreting adrenocortical tumor (Table 31.3). A markedly elevated free testosterone level (2.5 times the upper normal range) is considered typical of an adrenal androgen-secreting tumor, while moderately elevated free testosterone levels are often ovarian in origin. A DHEAS level greater than 800 \u03bcg/dL is typical of an adrenal tumor. An adrenal tumor is unlikely when serum DHEAS and urinary 17-ketosteroid excretion measurements are in the normal basal range and the serum cortisol concentration is less than 3.3 \u03bcg/dL after dexamethasone administration (195). The results of other dynamic tests, especially testosterone suppression and stimulation, are unreliable (196)."
        },
        {
            "id": "InternalMed_Harrison_3656",
            "title": "InternalMed_Harrison",
            "content": "A 32-year-old man was admitted to the hospital with weakness and hypokalemia. The patient had been very healthy until 2 months previously when he developed intermittent leg weakness. His review of systems was otherwise negative. He denied drug or laxative abuse and was on no medications. Past medical history was unremarkable, with no history of neuromuscular disease. Family history was notable for a sister with thyroid disease. Physical examination was notable only for reduced deep tendon reflexes. Sodium 139 143 meq/L Potassium 2.0 3.8 meq/L Chloride 105 107 meq/L Bicarbonate 26 29 meq/L BUN 11 16 mg/dL Creatinine 0.6 1.0 mg/dL Calcium 8.8 8.8 mg/dL Phosphate 1.2 mg/dL Albumin 3.8 meq/L TSH 0.08 \u03bcIU/L (normal 0.2\u20135.39) Free T4 41 pmol/L (normal 10\u201327)"
        },
        {
            "id": "Gynecology_Novak_5213",
            "title": "Gynecology_Novak",
            "content": "Affected girls may be but are not necessarily somewhat overweight. 2. In rare instances, menarche may be delayed, and primary amenorrhea may occur. 3. Basal levels of LH tend to be elevated in most affected individuals, and androgen production is invariably increased, even though circulating levels of androgens may be near the upper limits of the normal range in many affected women. Figure 29.21 Typical facial hirsutism in three women with polycystic ovarian syndrome. A: 25-year-old. 4. In anovulatory women, estrone levels are typically greater than estradiol levels. 5. Because circulating levels of estrogens are not diminished in PCOS and androgen levels are only mildly elevated, affected girls become both feminized and masculinized at puberty. This is an important feature because girls with classic forms of CAH who do not experience precocious puberty (and even those who do) only become masculinized at puberty (i.e., they do not develop breasts). 6."
        },
        {
            "id": "InternalMed_Harrison_3685",
            "title": "InternalMed_Harrison",
            "content": "A stuporous 22-year-old man was admitted with a history of behaving strangely. His friends indicated he experienced recent emotional problems stemming from a failed relationship and had threatened suicide. There was a history of alcohol abuse, but his friends were unaware of recent alcohol consumption. The patient was obtunded on admission, with no evident focal neurologic deficits. The remainder of the physical examination was unremarkable. Na+ 140 meq/L K+ 5 meq/L Cl\u2212 95 meq/L HCO3\u2212 10 meq/L Glucose 125 mg/dL BUN 15 mg/dL Creatinine 0.9 mg/dL Ionized calcium 4.0 mg/dL Plasma osmolality 325 mOsm kg/H2O Urinalysis revealed crystalluria, with a mixture of envelope-shaped and needle-shaped crystals."
        },
        {
            "id": "Gynecology_Novak_5569",
            "title": "Gynecology_Novak",
            "content": "In simple virilizing CAH, affected patients are diagnosed as virilized newborn females or as rapidly growing masculinized boys at 3 to 7 years of age. Diagnosis is based on basal levels of the substrate for 21-hydroxylase, 17-OHP; in cases of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency and in milder forms of the disorder with manifestations later in life (acquired, late onset, or adult-onset adrenal hyperplasia), diagnosis depends on basal and ACTH-stimulated levels of 17-OHP. Patients with morning follicular phase 17-OHP levels of less than 300 ng/dL (10 nmol/L) are likely unaffected. When levels are greater than 300 ng/dL, but less than 10,000 ng/dL (300 nmol/L), ACTH testing should be performed to distinguish between 21-hydroxylase deficiency and other enzyme defects or to make the diagnosis in borderline cases. Levels greater than 10,000 ng/dL (300 nmol/L) are virtually diagnostic of congenital adrenal hyperplasia."
        },
        {
            "id": "Pharmacology_Katzung_4104",
            "title": "Pharmacology_Katzung",
            "content": "A 4-year-old boy (height 90 cm, \u20133 standard deviations [SD]; weight 14.5 kg, approximately 15th percentile) presents with short stature. Review of the past history and growth chart demonstrates normal birth weight and birth length, but a progressive decrease in height per-centiles relative to age-matched normal ranges starting at 6 months of age, and orthostasis with febrile illnesses. Physical examination demonstrates short stature and mild generalized obesity. Genital examination reveals descended but small testes and a phallic length of \u20132 SD. Laboratory evaluations demonstrate growth hormone (GH) deficiency and a delayed bone age of 18 months. The patient is started on replacement with recombinant human GH at a dose of 40 mcg/kg per day subcutaneously. After 1 year of treatment, his height velocity has increased from 5 cm/y to 11 cm/y. How does GH stimulate growth in children? What other hormone deficiencies are sug-gested by the patient\u2019s history and physical examination? What"
        },
        {
            "id": "InternalMed_Harrison_3868",
            "title": "InternalMed_Harrison",
            "content": "The age at onset of menstrual cycles (menarche) and the pattern of the menstrual cycle should be ascertained; irregular cycles from the time of menarche onward are more likely to result from ovarian rather than adrenal androgen excess. Associated symptoms such as galactorrhea should prompt evaluation for hyperprolactinemia (Chap. 403) and possibly hypothyroidism (Chap. 405). Hypertension, striae, easy bruising, centripetal weight gain, and weakness suggest hypercortisolism (Cushing\u2019s syndrome; Chap. 406). Rarely, patients with growth hormone excess (i.e., acromegaly) present with hirsutism. Use of medications such as phenytoin, minoxidil, and cyclosporine may be associated with androgen-independent excess hair growth (i.e., hypertrichosis). A family history of infertility and/or hirsutism may indicate disorders such as nonclassic CAH (Chap. 406). Lipodystrophy is often associated with increased ovarian androgen production that occurs as a consequence of insulin resistance. Patients"
        },
        {
            "id": "Obstentrics_Williams_9134",
            "title": "Obstentrics_Williams",
            "content": "Phosphate (mg/dL) 2.5-4.3 3.1r-4.6 2.5-4.6 2.8-4.6 3,r26,r33,r39,r42 Potassium (mEq/L) 3.5-5.0 3.6-5.0 3.3-5.0 3.3-5.1 20,r26,r29,r39,r42,r63,r66 Protein, total (g/dL) 6.7-8.6 6.2-7.6 5.7-6.9 5.6-6.7 26,r29,r42 Sodium (mEq/L) 136-146 133-148 129-148 130-148 17,26,29,39,42,63,66 Urea nitrogen (mg/dL) 7-20 7-1r2 3-1r3 3-1r1 20,r39,r42 Uric acid (mg/dL) 2.5-5.6d 2.0-4.2 2.4-4.9 3.1r-6.3 17,r39,r42 Aldosterone (ng/dL) 2-9 6-104 9-104 15-101 21,r34,69 Angiotensin-converting 9-67 1-38 1-36 1-39 20, 54 Cortisol (19/dL) 0-25 7-1r9 10-42 12-50 42,r69 4-6 4-7 48,r49,r59 Thyroxine, total (T 4) 5.4-1r1.7 6.5-10.r1 7.5-1r0.3 6.3-9.7 29,r42 C-reactive protein (CRP) 0.2-3.0 Not reported 0.4-20.3 0.4-8.1 28 Dehydroepiandrosterone 1.3-6.8e 2.0-16.5 0.9-7.8 0.8-6.5 52 sulfate (DHEAS) Estradiol (pg/mU <20-443dJ 188--2497 1278-7192 6137-3460 1.3,52 Progesterone (ng/mL) <1-20d 8-48 99-342 13,n52 Prolactin (ng/mL) 0-20d 36-2n13 11n0-330 137-372 3,n13,n38,n49"
        },
        {
            "id": "InternalMed_Harrison_32553",
            "title": "InternalMed_Harrison",
            "content": "Abbreviations: P, plasma; RC, red cells; S, serum; WB, whole blood. Electrolytes Sodium 137\u2013145 mmol/L 137\u2013145 meq/L Potassium 2.7\u20133.9 mmol/L 2.7\u20133.9 meq/L Calcium 1.0\u20131.5 mmol/L 2.1\u20133.0 meq/L Magnesium 1.0\u20131.2 mmol/L 2.0\u20132.5 meq/L Chloride 116\u2013122 mmol/L 116\u2013122 meq/L CO2 content 20\u201324 mmol/L 20\u201324 meq/L PCO2 6\u20137 kPa 45\u201349 mmHg pH 7.31\u20137.34 Glucose 2.22\u20133.89 mmol/L 40\u201370 mg/dL Lactate 1\u20132 mmol/L 10\u201320 mg/dL Total protein: Lumbar 0.15\u20130.5 g/L 15\u201350 mg/dL Cisternal 0.15\u20130.25 g/L 15\u201325 mg/dL Ventricular 0.06\u20130.15 g/L 6\u201315 mg/dL Albumin 0.066\u20130.442 g/L 6.6\u201344.2 mg/dL IgG 0.009\u20130.057 g/L 0.9\u20135.7 mg/dL IgG indexb 0.29\u20130.59 Oligoclonal bands (OGB) <2 bands not present in matched serum sample"
        },
        {
            "id": "Gynecology_Novak_5219",
            "title": "Gynecology_Novak",
            "content": "Cosyntropin Stimulation Test The most commonly used stimulatory test involves measurement of 17\u03b1-hydroxyprogesterone 30 minutes after administration of a bolus of 0.25 mg of synthetic cosyntropin (Cortrosyn) (96). In normal women, this value seldom exceeds 400 ng/dL. Patients with classic 21-hydroxylase deficiency achieve peak levels of 3,000 ng/dL or higher. Patients with nonclassic 21-hydroxylase deficiency commonly achieve levels of 1,500 ng/dL or more. Heterozygous carriers achieve peak levels up to about 1,000 ng/dL. In hirsute women with hypertension, 11-deoxycortisol levels can be determined during the test. If both 11-deoxycortisol and 17\u03b1-hydroxyprogesterone levels are increased, the rare 11-hydroxylase deficiency is present. Only measurements of several steroid precursors after corticotropin stimulation can identify individuals with nonclassic forms of 3\u03b2-HSD deficiency."
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Pharmacology_Katzung_4629",
            "title": "Pharmacology_Katzung",
            "content": "A 66-year-old obese Caucasian man presented to an academic Diabetes Center for advice regarding his diabetes treatment. His diabetes was diagnosed 10 years previously on routine testing. He was initially given metformin but when his control deteriorated, the metformin was stopped and insulin treatment initiated. The patient was taking 50 units of insulin glargine and an average of 25 units of insulin aspartate pre-meals. He had never seen a diabetes educator or a dietitian. He was checking his glucose levels 4 times a day. He was smoking half a pack of cigarettes a day. On examination, his weight was 132 kg (BMI 39.5); blood pressure 145/71; and signs of mild peripheral neuropathy were present. Laboratory tests noted an HbA1c value of 8.1%, urine albumin 3007 mg/g creatinine (normal <30), serum creatinine 0.86 mg/dL (0.61\u20131.24), total choles-terol 128 mg/dL, triglycerides 86 mg/dL, HDL cholesterol 38 mg/dL, and LDL cholesterol 73 mg/dL (on atorvastatin 40 mg daily). How would you"
        },
        {
            "id": "InternalMed_Harrison_27954",
            "title": "InternalMed_Harrison",
            "content": "3. Assess: Serum electrolytes (K+, Na+, Mg2+, Cl\u2212, bicarbonate, phosphate) Acid-base status\u2014pH, HCO3\u2212, PCO2, \u03b2-hydroxybutyrate Renal function (creatinine, urine output) 4. Replace fluids: 2\u20133 L of 0.9% saline over first 1\u20133 h (10\u201320 mL/kg per hour); subsequently, 0.45% saline at 250\u2013500 mL/h; change to 5% glucose and 0.45% saline at 150\u2013250 mL/h when plasma glucose reaches 250 mg/dL (13.9 mmol/L). 5. Administer short-acting insulin: IV (0.1 units/kg), then 0.1 units/kg per hour by continuous IV infusion; increase twoto threefold if no response by 2\u20134 h. If the initial serum potassium is <3.3 mmol/L (3.3 meq/L), do not administer insulin until the potassium is corrected. 6. Assess patient: What precipitated the episode (noncompliance, infection, trauma, pregnancy, infarction, cocaine)? Initiate appropriate workup for precipitating event (cultures, CXR, ECG). 7."
        },
        {
            "id": "InternalMed_Harrison_27523",
            "title": "InternalMed_Harrison",
            "content": "History and physical \u00d7 \u00d7 Assessment of growth velocity \u00d7 \u00d7 Bone age \u00d7 \u00d7 LH, FSH \u00d7 \u00d7 Estradiol, testosterone \u00d7 \u00d7 DHEAS \u00d7 \u00d7 17-Hydroxyprogesterone \u00d7 TSH, T4 \u00d7 \u00d7 Complete blood count \u00d7 Sedimentation rate, C-reactive protein Electrolytes, renal function \u00d7 IGF-I, IGFBP-3 Abbreviations: ACTH, adrenocorticotropic hormone; DHEAS, dehydroepiandrosterone sulfate; FSH, follicle-stimulating hormone; hCG, human chorionic gonadotropin; IGF-I, insulin-like growth factor-I; IGFBP-3, IGF-binding protein 3; LH, luteinizing hormone; MRI, magnetic resonance imaging; TSH, thyroid-stimulating hormone; T4, thyroxine. height. Premature adrenarche can also occur in the absence of progressive pubertal development, but it must be distinguished from late-onset congenital adrenal hyperplasia and androgen-secreting tumors, in which case it may be termed heterosexual precocity. Premature adrenarche may be associated with obesity, hyperinsulinemia, and the subsequent predisposition to PCOS."
        },
        {
            "id": "Gynecology_Novak_5367",
            "title": "Gynecology_Novak",
            "content": "Assessment of the Pituitary and Hypothalamus karyotype only be performed if the patient is under age 30, it should be noted that rare patients with Turner syndrome developed amenorrhea after age 35. In addition, some patients who present over the age of 30 may have actually had the onset of POI at a younger age but were unaware because of the use of oral contraceptives. Therefore, consideration should be given to performance of karyotype, regardless of the patient\u2019s age. Testing for 21-hydroxylase antibody will identify women at risk for adrenal crisis. If a diagnosis of PCOS is suspected, the patient should have: 1. Documentation of hyperandrogenism (either by serum total testosterone and sex hormone binding globulin or free testosterone and/or by presence of physical findings such as acne, hirsutism, and androgenic alopecia), 2."
        },
        {
            "id": "InternalMed_Harrison_26469",
            "title": "InternalMed_Harrison",
            "content": "Laboratory Investigation The presenting clinical features of functional pituitary adenomas (e.g., acromegaly, prolactinomas, or Cushing\u2019s syndrome) should guide the laboratory studies (Table 403-2). However, for a sellar mass with no obvious clinical features of hormone excess, laboratory studies are geared toward determining the nature of the tumor and assessing the possible presence of hypopituitarism. When a pituitary adenoma is suspected based on MRI, initial hormonal evaluation usually includes (1) basal prolactin (PRL); (2) insulin-like growth factor (IGF) I; (3) 24-h urinary free cortisol (UFC) and/or overnight oral dexamethasone (1 mg) suppression test; (4) \u03b1 subunit, follicle-stimulating hormone (FSH), and luteinizing hormone (LH); and (5) thyroid function tests. Additional hormonal evaluation may be indicated based on the results of these tests. Pending more detailed assessment of hypopituitarism, a menstrual history, measurement of testosterone and 8 A.M. cortisol levels,"
        },
        {
            "id": "InternalMed_Harrison_32552",
            "title": "InternalMed_Harrison",
            "content": "Aluminum S <0.2 \u03bcmol/L <5.41 \u03bcg/L Arsenic WB 0.0\u20130.17 \u03bcmol/L 0\u201313 \u03bcg/L Cadmium WB <44.5 nmol/L <5.0 \u03bcg/L Coenzyme Q10 (ubiquinone) P 433\u20131532 \u03bcg/L 433\u20131532 \u03bcg/L \u03b2-Carotene S 0.07\u20131.43 \u03bcmol/L 4\u201377 \u03bcg/dL Copper S 11\u201322 \u03bcmol/L 70\u2013140 \u03bcg/dL Folic acid RC 340\u20131020 nmol/L cells 150\u2013450 ng/mL cells Folic acid S 12.2\u201340.8 nmol/L 5.4\u201318.0 ng/mL Lead S <0.5 \u03bcmol/L <10 \u03bcg/dL Children <0.25 \u03bcmol/L <5 \u03bcg/dL Mercury WB 0\u201350 \u03bcmol/L 0\u201310 \u03bcg/L Selenium S 0.8\u20132.0 \u03bcmol/L 63\u2013160 \u03bcg/L Vitamin A S 0.7\u20133.5 \u03bcmol/L 20\u2013100 \u03bcg/dL Vitamin B1 (thiamine) S 0\u201375 nmol/L 0\u20132 \u03bcg/dL Vitamin B2 (riboflavin) S 106\u2013638 nmol/L 4\u201324 \u03bcg/dL Vitamin B6 P 20\u2013121 nmol/L 5\u201330 ng/mL Vitamin B12 S 206\u2013735 pmol/L 279\u2013996 pg/mL Vitamin C (ascorbic acid) S 23\u201357 \u03bcmol/L 0.4\u20131.0 mg/dL Vitamin D 1,25-dihydroxy, total S, P 36\u2013180 pmol/L 15\u201375 pg/mL Vitamin D 25-hydroxy, total P 75\u2013250 nmol/L 30\u2013100 ng/mL Vitamin E S 12\u201342 \u03bcmol/L 5\u201318 \u03bcg/mL Vitamin K S 0.29\u20132.64 nmol/L 0.13\u20131.19 ng/mL Zinc S 11.5\u201318.4 \u03bcmol/L 75\u2013120 \u03bcg/dL"
        },
        {
            "id": "InternalMed_Harrison_3617",
            "title": "InternalMed_Harrison",
            "content": "A 63-year-old man was admitted to the intensive care unit (ICU) with a severe aspiration pneumonia. Past medical history included schizophrenia, for which he required institutional care; treatment had included neuroleptics and intermittent lithium, the latter restarted 6 months before admission. The patient was treated with antibiotics and intubated for several days, with the development of polyuria (3\u20135 L/d), hypernatremia, and acute renal insufficiency; the peak plasma Na+ concentration was 156 meq/L, and peak creatinine was 2.6 mg/dL. Urine osmolality was measured once and reported as 157 mOsm/kg, with a coincident plasma osmolality of 318 mOsm/kg. Lithium was stopped on admission to the ICU. On physical examination, the patient was alert, extubated, and thirsty. Weight was 97.5 kg. Urine output for the previous 24 h had been 3.4 L, with an IV intake of 2 L/d of D5W."
        },
        {
            "id": "Gynecology_Novak_5443",
            "title": "Gynecology_Novak",
            "content": "A family history should be obtained to disclose evidence of idiopathic hirsutism, PCOS, congenital or adult onset adrenal hyperplasia (CAH or AOAH), diabetes mellitus, and cardiovascular disease. A history of drug use should be obtained. In addition to drugs that commonly cause hypertrichosis, anabolic steroids and testosterone derivatives may cause hirsutism and even virilization. During the physical examination, attention should be directed to obesity, hypertension, galactorrhea, male-pattern baldness, acne (face and back), and hyperpigmentation. With virilization, the presence of an androgen-producing ovarian neoplasm or Cushing syndrome must be considered. In many cases of Cushing syndrome, the patient\u2019s presenting symptom is hirsutism. This devastating disorder may masquerade as other disorders such as AOAH and PCOS. Before making these diagnoses, the physician should search for the physical signs of the syndrome such as \u201cmoon face,\u201d plethora, purple striae, dorsocervical and"
        }
    ],
    "scores": [
        0.03487479792469353,
        0.02807982906642983,
        0.025942114438063983,
        0.02267190872648782,
        0.022667228897554296,
        0.022003259295026556,
        0.02183582648298655,
        0.02092507535161984,
        0.019764793279183714,
        0.019694244604316548,
        0.019327731092436976,
        0.01905453225660103,
        0.018518518518518517,
        0.01827436582109479,
        0.018207282913165264,
        0.01809771141048531,
        0.017998385794995964,
        0.017698425074068297,
        0.017564043564963952,
        0.017545209696036936,
        0.01747674767476748,
        0.017220990391722098,
        0.016849557522123894,
        0.016797541823147834,
        0.016420147260050824,
        0.016328978938949613,
        0.016146326080100915,
        0.01588198367859385,
        0.015584568336861915,
        0.015547905909351694,
        0.015546218487394958,
        0.01552757793764988
    ]
}